Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
Roche Holding licensed a new weight-loss drug from Zealand Pharma, bolstering the drugmaker’s effort to get into a hot market dominated by Novo Nordisk and Eli Lilly & Co.

Mar 21, 2025 0
Mar 21, 2025 0
Mar 21, 2025 0
Mar 21, 2025 0
Mar 21, 2025 0
Mar 21, 2025 0
Or register with email
Jan 28, 2025 0
Mar 1, 2025 0
Jan 26, 2025 0
Feb 24, 2025 0
Feb 24, 2025 0
Jan 30, 2025 1
Jan 29, 2025 0
Jan 28, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.